Back
G
General University Hospital
Scholars73
Papers30
Citations0
Related Papers (28)
Publication Date
Trials in progress: CARMAN – study protocol of a randomized controlled, international, multicenter, open-label phase II trial evaluating early treatment intensification in patients with high-risk mantle cell lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with rituximab and ibrutinib and 6 months ibrutinib maintenance as compared to standard of care induction and maintenance
BMC Cancer
IF3.4

